AbbVie to buy Stemcentrx in $5.8 billion deal
April 28, 2016 at 10:01 AM EDT
AbbVie agreed to buy Stemcentrx, gaining lung cancer treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.